Macro
Intravacc enrols first subject in intranasal Covid-19 booster trial
Intravacc has enrolled the first subject in a Phase I clinical trial analysing its intranasal subunit vaccine for Covid-19, Avacc 10, as…
Anticoagulant unbeneficial for Covid-19 University of Cambridge trial finds
The University of Cambridge in the UK has reported results from the HEAL-COVID clinical trial, where the oral anticoagulant Apixaban…
Pfizer and BioNTech initiate Phase I trial of Covid-19 vaccine candidate
Pfizer and BioNTech have commenced a Phase I clinical trial of the Covid-19 vaccine candidate BNT162b4, which aims to improve…
Daiichi Sankyo’s Covid-19 vaccine trial meets primary endpoint
Daiichi Sankyo has reported that the Phase I/II/III clinical trial of a messenger ribonucleic acid (mRNA) vaccine for Covid-19, DS-5670, as a booster…
Moderna’s Omicron-targeting vaccines meet endpoint in Phase II/III trial
Moderna has reported findings from a Phase II/III clinical trial where bivalent Omicron-targeting booster candidates, mRNA-1273.214 and mRNA-1273.222, met the primary endpoint of…
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Novavax reports Phase III topline data of Omicron subvariant vaccines
Novavax has reported topline results from its Phase III clinical trial assessing Omicron subvariant vaccine candidates for Covid-19. In the…
Cholesterol drug fails in Penn Medicine-led Covid-19 clinical trial
Penn Medicine has reported that the cholesterol-lowering drug fenofibrate showed no substantial impact on Covid-19 outcomes in a clinical trial.…
Pfizer and BioNTech report data from Omicron-based Covid-19 booster trial
Pfizer and BioNTech have reported findings from a Phase II/III clinical trial of an Omicron BA.4/BA.5-adapted bivalent Covid-19 booster vaccine (Pfizer-BioNTech COVID-19 Vaccine,…
Pfizer, BioNTech begin Phase I influenza-Covid-19 combination vaccine trial
Pfizer and BioNTech have commenced a Phase I clinical trial of a messenger ribonucleic acid (mRNA)-based combination vaccine candidate for…
Akston reports positive Phase II data for Covid-19 booster vaccine
Akston Biosciences has reported positive top-line data from its Phase II clinical trial of AKS-452, a 'universal' booster vaccine for Covid-19. …
Rigel reports Phase III data of fostamatinib for Covid-19
Rigel Pharmaceuticals has reported top-line data from the Phase III FOCUS clinical trial of fostamatinib in Covid-19 patients admitted to the hospital. …
Bayer Advances Regenerative Farming
Concept: German pharmaceutical and biotechnology company Bayer has partnered with American Perdue AgriBusiness (Perdue), an operating company of Perdue Farms…
Minerva Intelligence Unveils First Canadian Climate Risk Data API
Concept: Canadian software development startup Minerva Intelligence has launched an AI-powered application programming interface (API) called climate85 API for climate…
Inovio to stop Covid-19 heterologous booster vaccine development
Inovio has announced plans to discontinue its internally financed efforts for developing INO-4800 as a heterologous booster vaccine for Covid-19. …
Codagenix and SII begin subject dosing in Phase III Covid-19 vaccine trial
Codagenix and the Serum Institute of India (SII) have commenced subject dosing in a Phase III clinical trial of the…